2 / 3 / 4/JUNE

2017MARIS CONFERENCE CENTER

HERSONISSOS, CRETE

CARDIO ELECTRICS 2017

&

DIAGNOSTIC &

THERAPEUTIC DEVELOPMENTS IN

CARDIOLOGY

UNDER THE AUSPICES OF HELLENIC CARDIOVASCULAR

RESEARCH SOCIETY

KOSMOS TRAVEL

CONGRESS SECRETARIAT KOSMOS TRAVEL

account@kosmostravel.gr | ticketing@kosmostravel.gr

2

JUNE

2342017

3

,

, PULSE 2017.

Pulse , 26 . , , .

, PULSE , , , , : , , , , .

, , . . . , . , , .

PULSE, , , . .

..

1 2017

02.06.2017

4

02.06.2017

ONE-DAY MEETING ON ECHOCARDIOGRAPHY AND TOTAL CARDIAC IMAGING

09:00 09:15 I IntroductIon Room I ./F.Parthenakis

- ONE DAY SESSION Of ELECTROPHYSIOLOGY- PACING 09:00 09:15 II IntroductIon Room II ./E.Simantirakis

09:15 10:00 I cLInIcAL tutorIAL I Room I

3D: H , . 3D ULTRASOUND: THE EXAMINATIONS METHODOLOGY AND ITS CLINICAL SIGNIFICANCE IN SPECIFIC HEART DISEASES.: . - . Chairs: Ch. Karvounis - A. Patrianakos

1. . Serious asymptomatic mitral valve regurgitation. ./D.Patsouras

2. . Serious asymptomatic aortic valve stenosis. ./E.Anagnostou

3. . Problems in right chambers heart valves. ./K.Papadopoulos

4. . Prosthetic heart valves disfunctions. A./A.Stefanidis

Friday 02.06.2017

5

09:15 - 10:00 II round tAbLe Room II

- CARDIAC PACING- DEFIbRILLATION: . - . Chairs: E. Simantirakis - E. Christoforatou

.Pacing algorithms with Clinical importance. ./S.Tzeis

: -.Endocardial transvenous implantable pacemakers: New data-controversies../E.Christoforatou

: ;Subcutaneous Defibrillators: Should they replace the transvenous ones?./E.Kanoupakis

: .Cardiac resynchronization: Contemporary technologies../S.Sideris

10:00 -11:00 I cLInIcAL tutorIAL II Room I . . CARDIAC IMAGING OF MULTIPLE AND DEVELOPING TECHNOLOGIES. THE CHALLENGES IN TREATMENT OF SPECIFIC HEART PRObLEMS.: . - . Chairs: G. Athanasopoulos - I. Mantas

1. 2D 3D speckle tracking . Clinical value of high resolution analysis of 2D and 3D speckle tracking in everyday clinical practice. ./E.Matsakas

2. MRI. . Imaging of cardiac fibrosis with MRI. ./Th.Karamitsos

02.06.2017

6

3. . . Imaging of vulnerable atheromatous plaque. The Holy Grail in investigation of coronary artery disease. ./E.Skalidis

10:00 - 11:00 II cLInIcAL tutorIAL Room II PRESENTATION OF CLINICAL CASES.: . - . Chairs: V. Vassilikos - E. Kanoupakis

-Right Ventricle Lipoma- Syncope./S.Sideris

- Superior vena cava syndrome -complete AV block./D.Lempidakis

-Arrhythmia induced cardiomyopathies - Treatment ./E.Christoforatou

- Pulmonary Embolism- Complete AV block./P.Papakonstantinou

11:00 11:30 | break

Friday 02.06.2017

7

11:30 - 12:30 I dIStInGuISHed LectureS Room I

: . - . Chairs: D. Tousoulis - A. Nikolaou

1. . Management of extra- and intracranial arterial stenosis. ./P.Papanagiotou(Germany)

2. . Detection of vulnerable atheromatous plaque using positron emission drugs. .(USA)/G.Papadakis(USA)

11:30 - 13.00 II round tAbLe Room II : ATRIAL FIbRILLATION: THERAPEUTIC CONSIDERATIONS : . - . Chairs: G. Theodorakis - G. Andrikopoulos

: ;Ablation of atrial fibrillation: for which patients and how?./E.Kalergis

: .Antiarrhythmic drugs: What drug for which patient../Ath.Manolis

: Anticoagulation therapy: Optimal choices../H.Mavrakis

-: .Atrial high-rate episodes recorded by pacemakers-defibrillators: Their significance and treatment../E.Simantirakis

02.06.2017

8

12:30 13:30 K I cLInIcAL tutorIAL III Room I 6 .SPECIALISTS DISCUSS 6 SPECIAL CLINICAL CASE REPORTS.: . - . Chairs: I. Oikonomidis - N. Kouris

1. ONASEIO ./D.Tsiapras

2. .. G.H.NIKAIAS ./A.Stefanidis

3. ... G.H.I. HATZIKOSTA ./D.Patsouras

4. IATRIKO DIAVALKANIKO THESSALONIKIS ./h.Zaglavara

5. PAGNI ./A.Patrianakos

6. PAGNI ./A.Zacharaki

Friday 02.06.2017

9

13:00 - 14:00 II cLInIcAL tutorIAL Room II

: . . Chairs: E. Iliodromitis E. Papadakis

40 ;Defibrillator implantation the first 40 days after acute myocardial infarction../E.Foukarakis

;Ablation of accessories pathways../E.Kalergis

;What we should do for the patient with frequent Ventricular Extrasystoles?./S.Tzeis

; Channelopathies- When the defibrillator should be implanted. A./A.Kostopoulou

13:30 14:30 I SPecIAL LectureS Room I : . - . Chairs: G. Karatasakis - E. Foukarakis

1. HfpEf HfrEf: ; HfpEf and HRrEf: Two different entities or a total? ./I.Paraskevaidis

2. . . Management of patients with acute aortic syndrome.The role of cardiac imagine. ./L.Rallidis

3. . . Echocardiography in Catheterization laboratory. A co-working experience of interventional cardiologists. ./K.Angeli

02.06.2017

10

14:00 - 14:30 II Lecture Room II

: . Chair: E. Simantirakis

.The future cardiac patient../E.Iliodromitis

14:30 - 17:00 () | break (Lunch)

15:00 - 16:00 II Meet tHe exPertS Room II ARNIS - .THE USE OF ARNIS IN THE CLINICAL MANAGEMENT OF HFrEF PATIENTS.: . Chair: D. Tziakas

Clinical Cases Discussion ./G.Halikias

15:00 - 16:00 III Meet tHe exPertS Room III ARNIS - .THE USE OF ARNIS IN THE CLINICAL MANAGEMENT OF HFrEF PATIENTS.: . Chair: E. Simantirakis

Clinical Cases Discussion ./Ch.Chrysohoou

Friday 02.06.2017

11

17:00 - 18:00 K IV I CLINICAL TUTORIAL IV Room I . .DIAGNOSTIC AND THERAPEUTIC APPROACH OF CARDIOMYOPATHIES. NEW AND ESSENTIAL.: . - . Chairs: D. Tziakas - El. Papadakis

1. , . Methodology of sudden cardiac death assessment in patients with hypertrophic cardiomyopathy. ./S.Maragoudakis

2. . Diagnostic and therapeutic approach of arrhythmogenic right ventricle. ./A.Anastasakis

3. . Study and Monitoring Methodology of patients with acute myocarditis. ./R.Vrettou

4. . . Diagnostic approach of drugs cardiotoxicity. The role of imaging. ./M.Marketou

02.06.2017

12

18:00 19:00 SANOFI I SATELLITE SYMPOSIUM SANOFI Room I ALIROCUMAb.ALIROCUMAb: REDEFINING WHAT IS POSSIbLE IN THE MANAGEMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA.: . Chairman: F. Parthenakis

LDL-C: ;LDL-C: The lower the better?E./E.Skalidis

alirocumab .The role of alirocumab in the management of high and very high risk patients../M.Hamilos

19:00 - 19:30 I dIStInGuISHed Lecture Room I CT A, .CT ANGIOGRAPHY, TODAY AND TOMORROW.: . - . Chairs: P. Vardas - F. Parthenakis

: J.J.Bax, Speaker: J.J. Bax, ESC President

19:30 20:00 | break

Friday 02.06.2017

13

20:00 21:00 V I CLINICAL TUTORIAL V Room I .THE MOST PREFERAbLE bLOODLESS DIAGNOSTIC TECHNIQUE FOR THE INVESTIGATION OF POSSIbLE CORONARY DISEASE.: . - . Chairs: A. Kranidis - I. Vlaseros

1. . ; Stress echocardiography. Is it the most preferable technique? ./I.Oikonomidis

2. . . Stress cardiac MRI. The dominating examination. ./M.Kalantzi

3. SPECT /PET. OI . SPECT/PET. The widest accepted techniques. ./I.Vasiliadis

4. CT . . Cardiac CT angiography. A Rapidly improving and reliable technique. ./K.Pagonidis

03.06.2017

14

09:00 - 09:15 I Introductory SPeecH Room I . .CLINICAL AND LAbORATORY CARDIOLOGY. SHORT MESSAGES AND HIGHLIGHTS.

: . - . Chairs: E. liodromitis - G. Theodorakis

: . Speaker: P. Vardas

09:15 09.45 I dIStInGuISHed Lecture Room I

. ESC/2016 .HEART FAILURE. THE ESC / 2016 GUIDELINES, APPLICATION IN DAILY CLINICAL PRACTICE.: . - . Chairs: E. Iliodromitis - G.Theodorakis

: . Speaker: G. Filippatos

: . / .Comments-Discussion: G. Giamouzis / G. Giannakoulas

09:45 - 10:30 I dIStInGuISHed Lecture Room I

(ESC)LECTURE bY THE PRESIDENT OF EUROPEAN SOCIETY OF CARDIOLOGY (ESC)

.The role of imaging in the Transcatheter valve therapy.: . - . Chairs: S. Konstantinides - D. Alexopoulos

: J.J. Bax Speaker: J.J. Bax

Saturday 03.06.2017

15

10:30 - 11:00 AMGEN I SAteLLIte SPeecH AMGen Room I PCSK9 : EVOLOCUMAb.PCSK9 INHIbITION FOLLOWING THE OUTCOMES TRIALS: EVOLOCUMAb DATA.: . Chairs: P. Vardas

: . Speaker: L. Rallidis

11:00 11:30 | break

11:30 12:30 bAyer/eLPen I SAteLLIte SyMPoSIuM bAyer/eLPen Room I

. .ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIbRILLATION. FOCUS ON ObjECTS OF HIGH CLINICAL IMPORTANCE. : . - . Chairs: P. Vardas - F. Parthenakis

.Management of thrombotic risk in patients with non-valvular atrial fibrillation and high cardiovascular risk../H.Mavrakis

2017. " " .Anticoagulation in Atrial fibrillation 2017. The Importance of Real Data in Daily Clinical Practice../S.Konstantinides

03.06.2017

16

12:30 13:30 VI I CLINICAL TUTORIAL VI Room I

. .ISCHEMIC HEART DISEASE. PATHOPHYSIOLOGY, AS A CENTRAL AXIS OF THERAPEUTIC OPTIONS.: